Mavenclad Tablet
Product Images NDC 44087-4000

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mavenclad (NDC 44087-4000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emd Serono, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mavenclad 01)

Chemical structure of cladribine, the active ingredient in Mavenclad 10 mg oral tablets by EMD Serono, Inc. The structure shows a chlorinated purine nucleoside with nitrogenous bases and sugar moieties.*

FDA Label Image

Principal Display Panel (4 Tablet Blister Pack Carton)

Mavenclad (cladribine) tablets, 10 mg per tablet, shown in a label panel indicating a package of 4 tablets. The label also includes dosage information noting the tablets come in four child-resistant day packs, with directions for oral administration and warnings about separating ingestion with other medicines. The labeler is EMD Serono, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.